✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Confused about any medicine? Just ask Practo AIFREE
50000+ health queries resolved in last month
Chat with Practo AI on Whatsapp
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Description
Deritas 7.5 Tablet is used to treat an overactive bladder, a condition characterised by symptoms such as a frequent and sudden urge to urinate, inability to control urination, and leaking of urine. This medicine improves the ability to control urination by relaxing the muscles in the urinary bladder thus relieving symptoms associated with an overactive bladder.
Deritas 7.5 Tablet shows side effects like dry mouth, constipation, nausea, vomiting, and indigestion. Most of these side effects resolve with time. However, if they persist or worsen, consult your doctor at the earliest. Avoid driving vehicles or operating machines as Deritas 7.5 Tablet may cause dizziness or blurry vision in some people.
Deritas 7.5 Tablet can be taken with or without food. Your doctor will decide the dose based on your clinical condition. It may take some time for your bladder to adapt and your symptoms to improve. Do not stop taking this medicine without consulting your doctor.
Deritas 7.5 Tablet is not recommended for use if you are allergic to it or if you have urinary retention (when you are unable to empty the bladder completely), severe liver problems, narrow-angle glaucoma (an eye condition that causes an increase in fluid pressure within the eye when the drainage canal that allows fluid to drain from the eye becomes blocked), or gastric retention (when there is delayed gastric emptying, causing your stomach to take too long to empty its contents). Inform your doctor about the medications you are taking to avoid any undesired effects.
Deritas 7.5 Tablet is not recommended for children under 18 years of age. Consult your doctor if you are pregnant or are breastfeeding.
QUICK LINKS:
Substitutes
List of substitutes for Deritas 7.5 Tablet
Side effects
Major & minor side effects for Deritas 7.5 Tablet
Dry mouth
Constipation
Dry eyes
Nausea and Vomiting
Abdominal pain
Dry skin
Cough
Nasal dryness
Weight gain
Headache
Dizziness
Back pain
Uses of Deritas 7.5 Tablet
What is it prescribed for?
Overactive Bladder
Overactive bladder (OAB) is a condition of the urinary bladder characterised by uncontrolled leakage of urine, a frequent or sudden urge to urinate, etc. Deritas 7.5 Tablet is used to treat the symptoms associated with an overactive bladder.
Concerns
Commonly asked questions
How long does it take for this medicine to take effect?
The time Deritas 7.5 Tablet takes to show its effect is not known.How long do the effects of this medicine last?
The amount of time for which Deritas 7.5 Tablet remains active in the body is not clinically established.Is it safe to consume alcohol while taking this medicine?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.Is this a habit forming medicine?
Deritas 7.5 Tablet has no habit-forming tendency.Can this medicine be taken during pregnancy?
Deritas 7.5 Tablet is not recommended for use in pregnancy unless absolutely necessary. Consult your doctor before taking this medicine if you are pregnant.Can this medicine be taken while breast-feeding?
It is not known whether Deritas 7.5 Tablet passes into breastmilk. Hence, consult your doctor before taking this medicine if you are breastfeeding.
Allergy
Avoid taking Deritas 7.5 Tablet if you are allergic to it. Seek medical attention if you experience symptoms such as skin rash, hives (painful itchy eruptions that sting), swelling (especially of the face, lips, tongue, etc.), breathing difficulty, etc.
Severe liver impairment
Deritas 7.5 Tablet is broken down in the liver. Using this medicine when you have a pre-existing liver problem may lead to the worsening of the liver condition and other undesirable effects. Hence, Deritas 7.5 Tablet is not recommended for use if you have severe liver problems.
Urinary retention
Urinary retention is when you are unable to empty the bladder completely. Deritas 7.5 Tablet is not recommended for use if you have urinary retention as it may further worsen your condition.
Narrow angle glaucoma
Narrow-angle glaucoma is an eye condition that causes an increase in fluid pressure within the eye when the drainage canal that allows fluid to drain from the eye becomes blocked. Deritas 7.5 Tablet is not recommended for use if you have narrow-angle glaucoma as it may suppress the fluid drainage from the eye and worsen your condition.
Gastric retention
Gastric retention occurs when there is delayed gastric emptying, causing your stomach to take too long to empty its contents. It may occur due to surgery, gastrointestinal obstruction (a blockage that keeps food or liquid from passing through your small intestine or large intestine), severe colitis (swelling in the large intestine), etc. Deritas 7.5 Tablet is not recommended if you have stomach and intestinal problems that may lead to gastric retention as it may worsen your condition.
Warnings for special population
Pregnancy
Deritas 7.5 Tablet is not recommended for use in pregnancy unless absolutely necessary. Consult your doctor before taking this medicine if you are pregnant.
Breast-feeding
It is not known whether Deritas 7.5 Tablet passes into breastmilk. Hence, consult your doctor before taking this medicine if you are breastfeeding.
General warnings
Liver impairment
Deritas 7.5 Tablet is broken down in the liver. Hence it should be used with caution if you have moderate liver problems as it may lead to the accumulation of unused medicine in the body, thus increasing the risk of undesired effects.
Use in children
Deritas 7.5 Tablet is not recommended for use in children less than 18 years of age as the safety and efficacy data are not clinically established.
Driving or operating machines
Use of Deritas 7.5 Tablet may cause symptoms such as dizziness, drowsiness, blurred vision, etc., in some people. Avoid performing activities such as driving or operating machines if you experience any of these symptoms during treatment with Deritas 7.5 Tablet.
Central nervous system effects
Deritas 7.5 Tablet should be used with caution as it may cause headache, hallucinations, confusion, and dizziness.
Missed Dose
If you have forgotten to take Deritas 7.5 Tablet, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Overdose
Do not take an excess dose than prescribed by your doctor. Seek emergency medical treatment in case you suspect an overdose of Deritas 7.5 Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Atazanavir
Clotrimazole
Itraconazole
Disease interactions
Disease
Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Deritas 7.5 Tablet with or without food. Do not crush, break, or chew the tablet. Do not take a higher dose than advised.
It may take some time for your bladder to adapt and your symptoms to improve. Do not stop taking this medicine if you do not notice an immediate improvement in your symptoms.
Avoid caffeine-containing drinks such as tea, coffee, etc., as they will make you want to pass urine frequently.
Your doctor may also recommend some exercises to strengthen your bladder muscles.
Miscelleneous
How it works
Deritas 7.5 Tablet relaxes the urinary bladder muscles; this helps the bladder to retain a larger amount of urine and prevents the symptoms of an overactive bladder.
Legal Status
Classification
Category
Urinary antispasmodics
Schedule
Schedule H
Drugs, H., 2022. Darifenacin: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 11 July 2022].
Pubchem.ncbi.nlm.nih.gov. 2022. Darifenacin. [online] Available at: [Accessed 11 July 2022].
Information on this page was last updated on 30 Aug 2022
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.